This is a modal window.
Intravascular Lithotripsy for Treatment of Severely Calcified Coronary Artery Disease. The Distrupt CAD III Oct Sub-study.
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its...
Simplify your procedures with Intravascular Lithotripsy (IVL) by safely modifying intimal and medial calcium to achieve optimal outcomes while minimising trauma, complications and costs due to its unique MOA.
Prior to use, please reference the instructions for use and important safety information: https://shockwavemedical.com/important-safety-information-universal/
Discover more at ShockwaveIVL.com
Speakers
Richard Shlofmitz
Speaker
Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The... Dr Richard A. Shlofmitz, MD, FACC is the Chairman of Cardiology at St. Francis Hospital, The Heart Center®, in Roslyn, New York. A pioneer in interventional cardiology, Dr. Shlofmitz has worked to advance the field, with a focus on optimizing outcomes with the development of Precision PCI. He is a founding co-director of the annual Intravascular Imaging and Coronary Physiology Workshop. Performing over 1,000 coronary interventions annually, he has one of the largest volumes of experience in PCI. He has the most clinical experience with orbital atherectomy and OCT world-wide. His clinical research interests focus on optimizing coronary interventions and he serves on multiple scientific advisory boards and clinical trial steering committees to further this mission. Dr Shlofmitz has been one of the largest enrollers for multiple clinical trials, including TWILIGHT, ILUMIEN III, and Onyx, with more than 75 publications in peer-reviewed journals and was first to perform coronary intravascular lithotripsy (IVL) in North America as part of the DISRUPT CAD III trial.
